By sourcing all of our products from the United Kingdom through informed consent for commercial use, we ensure that we provide you with the highest quality goods. We take pride in our commitment to ethical and responsible practices and are confident that you will be satisfied with the products you receive.
No product(s) found.
Stemnovate’s Primary Feline Fibroblasts (SV-FF-2-500-F) are created by isolating, plating, and expanding cells in culture before being harvested for cryopreservation, resulting in the highest purity, viability, and plating efficiency. The key features of these primary Feline fibroblasts (SV-FF-2-500-F) are:
Stemnovate’s Primary Feline Fibroblasts (SV-FF-2-500-F) are negative for tuberculosis and mycoplasma. Our recommendation is not to freeze and thaw the cells repeatedly. Additional options are available for genotyping for drug-metabolizing enzymes along with tailored media to meet custom research needs.
Stemnovate’s Feline Primary Dermal Fibroblasts have many applications, for example:
Dermal Fibroblasts are responsible for producing the extracellular matrix forming the connective tissue of the skin and play a crucial role during wound healing. For instance, they play an important role in the progression of inflammation by secreting various factors that define the tissue microenvironment and modulate immune cell functions.
Dermal fibroblasts provide an excellent model system to study many aspects of cell physiology. For instance, they are integral to hundreds of research publications related to skin biology and reprogramming/induced pluripotency studies.
Dr. Shinya Yamanaka was awarded the Nobel Prize in 2012 (Takanashi, 2007; 2009) for using Human Dermal Fibroblasts in order to create induced pluripotent stem cells (iPSC) by using Oct3/4, Sox2, Klf4, and c-Myc.
All animal cells used by Stemnovate are acquired with consent from the owner, accompanied by a veterinary certificate and are sourced only from necessary surgeries.